Iparomlimab is an anti-human PD-1/CD279/PDCD1 IgG4kappa antibody. Iparomlimab also targets to human monoclonal PSB103 gamma4-chain, disulfided with human monoclonal PSB103 kappa-chain to form a dimer. Iparomlimab can be used for Oncology research[1].
Molecular Weight:
(146.7 kDa)
Purity:
98.33
CAS Number:
[2417649-33-1]
Target:
PD-1/PD-L1
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted